ARTICLE | Clinical News
Ark preclinical data
June 4, 2007 7:00 AM UTC
Rats receiving Scavidin plus a low dose of IV yttrium-90 survived 32% longer than animals receiving yttrium-90 alone or controls. AKT said the dose of yttrium-90 would typically be subtherapeutic. Sca...